“Long-Term Proactive Management of Psoriasis Vulgaris With Fixed-Dose Combination of Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam: Results from a Phase III Randomized Controlled Trial”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s32. https://doi.org/10.25251/skin.4.supp.32.